ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.96
-0.36 (-2.51%)
Jun 12, 2025, 4:08 PM HKT

HKG:1541 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5,8332,10211,187--
Market Cap Growth
-81.21%-81.21%---
Enterprise Value
5,1771,65510,650--
Last Close Price
14.325.1629.90--
PS Ratio
68.9124.831319.67--
PB Ratio
8.082.9113.57--
P/TBV Ratio
8.072.9113.57--
EV/Sales Ratio
61.1619.561256.23--
Debt / Equity Ratio
0.200.200.100.02-0.01
Asset Turnover
0.090.090.010.01-
Quick Ratio
3.513.515.2612.300.27
Current Ratio
4.044.045.9312.600.28
Return on Equity (ROE)
-44.38%-44.38%-49.68%--
Return on Assets (ROA)
-21.43%-21.43%-26.59%-26.29%-
Return on Capital (ROIC)
-23.51%-23.51%-28.19%--
Earnings Yield
-5.76%-15.99%-3.74%--
FCF Yield
-2.53%-7.01%-3.65%--
Buyback Yield / Dilution
-4.24%-4.24%-9.05%-284.99%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.